AI assistant
Sending…
GENTRACK GROUP LIMITED — Director's Dealing 2025
Dec 11, 2025
65024_rns_2025-12-11_00066651-70ba-4411-9790-391659287834.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [106 x 29] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| ToNZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | Gentrack GroupLimited(GTK) | |
| Date this disclosure made: | 12-Dec-25 | |
| Date of last disclosure: | 12-Dec-24 | |
| Director or senior managergiving disclosure | ||
| Full name(s): | John Edward Frederick Priggen | |
| Name of listed issuer: | Gentrack GroupLimited(GTK) | |
| Name of related body corporate (if applicable): | Not applicable | |
| Position held in listed issuer: | Chief Financial Officer | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class of affected quoted financial products: Ordinary Shares in Gentrack Group Limited(NZX:GTK) Nature of the affected relevant interest(s): Receipt of 470,453 ordinary shares upon vesting of performance rights under the Gentrack Senior Management LTI Scheme and October 2022 LTI Award. |
||
| Class of affected quoted financial products: | Ordinary Shares in Gentrack Group Limited(NZX:GTK) |
|
| Nature of the affected relevant interest(s): | Receipt of 470,453 ordinary shares upon vesting of performance rights under the Gentrack Senior Management LTI Scheme and October 2022 LTI Award. |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 180,571 | |
| Number held in class after acquisition or disposal: | 651,024 | |
| Current registered holder(s): | Not applicable as a new issue | |
| Registered holder(s) once transfers are registered: | John Edward Frederick Priggen | |
| Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) Type of affected derivative: Not applicable Class of underlyingfinancialproducts: Not applicable Details of affected derivative- The notional value of the derivative (if any) or the notional amount of underlying financialproducts(if any): Not applicable A statement as to whether the derivative is cash settled orphysicallysettled: Not applicable |
||
| Not applicable | ||
| Not applicable | ||
| The notional value of the derivative (if any) or the notional amount of underlying financialproducts(if any): |
Not applicable | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | Not applicable | |
| Maturitydate of the derivative(if any): | Not applicable | |
| Expirydate of the derivative(if any): | Not applicable | |
| Theprice specified in the terms of the derivative(if any): | Not applicable | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: |
Not applicable | |
| For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
||
| Parties to the derivative: | Not applicable | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
Not applicable | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 2 |
Details of transactions requiring disclosure-
| Date of transaction: | 10-Dec-25 | |
|---|---|---|
| Nature of transaction: | Issue of new ordinary shares in Gentrack Group Limited upon vesting of performance rights under Gentrack Senior Management LTI Scheme and October 2022 LTI Award. |
|
| Name of anyotherpartyorparties to the transaction(if known): | Gentrack GroupLimited as issuer | |
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration: |
NIL | |
| Number of financialproducts to which the transaction related: | 470,453 | |
| If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— |
||
| Whether relevant interests were acquired or disposed of duringa closedperiod: | No | |
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod: |
Not applicable | |
| Date of theprior written clearance(if any): | Not applicable | |
| Summary of other relevant interests after acquisition or disposal: Class ofquoted financialproducts: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- |
||
| Not applicable | ||
| Not applicable | ||
| Not applicable | ||
| Not applicable | ||
| Type of derivative: | Not applicable | |
| Details of derivative,- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
Not applicable | |
| A statement as to whether the derivative is cash settled or physically settled: | Not applicable | |
| Maturity date of the derivative (if any): | Not applicable | |
| Expiry date of the derivative (if any): | Not applicable | |
| The price's specified terms (if any): | Not applicable | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
Not applicable | |
| For that derivative relevant interest,- | ||
| Parties to the derivative: | Not applicable | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
Not applicable | |
| Certification I, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorisedperson: |
||
| Signature of person authorised to sign on behalf of director or officer: | ||
| Date of signature: | 12-Dec-25 | |
| Name and title of authorisedperson: | Anna Ellis, CompanySecretary |
More from GENTRACK GROUP LIMITED
Director's Dealing
2026
May 28
Director's Dealing
2026
May 24
M&A Activity
2026
May 17
Earnings Release
2026
May 17
Investor Presentation
2026
May 17
Interim / Quarterly Report
2026
May 17
Earnings Release
2026
May 17
Report Publication Announcement
2026
May 17
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
May 6